RARE-24. OBJECTIVE RESPONSE AND CLINICAL BENEFIT IN RECURRENT EPENDYMOMA IN ADULTS: FINAL REPORT OF CERN 08-02: A PHASE II STUDY OF DOSE-DENSE TEMOZOLOMIDE AND LAPATINIB

BACKGROUND: Ependymoma is a rare tumor for which the role of chemotherapy has not been established either for newly diagnosed or recurrent disease. We report on the first prospective adult clinical trial of chemotherapy for recurrent ependymoma. METHODS: Adult (> 18 years) were treated with dose-...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Neuro Oncol
Main Authors: Armstrong, Terri, Yuan, Ying, Wu, Jimin, Mendoza, Tito, Vera, Elizabeth, Omuro, Antonio, Lieberman, Frank, Robins, H, Gerstner, Elizabeth, Wu, Jing, Wen, Patrick, Mikkelsen, Tom, Aldape, Kenneth, Gilbert, Mark
Format: Artigo
Sprog:Inglês
Udgivet: Oxford University Press 2018
Fag:
Abstracts
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6217700/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy148.998
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker